24,707 Shares in Omega Healthcare Investors, Inc. (NYSE:OHI) Acquired by Algert Global LLC

Algert Global LLC bought a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 24,707 shares of the real estate investment trust’s stock, valued at approximately $846,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Hennion & Walsh Asset Management Inc. increased its holdings in Omega Healthcare Investors by 96.7% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock worth $690,000 after acquiring an additional 10,714 shares in the last quarter. Slagle Financial LLC grew its holdings in Omega Healthcare Investors by 102.1% during the 4th quarter. Slagle Financial LLC now owns 94,586 shares of the real estate investment trust’s stock valued at $2,900,000 after buying an additional 47,785 shares in the last quarter. Private Advisor Group LLC grew its holdings in Omega Healthcare Investors by 6.6% during the 1st quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust’s stock valued at $911,000 after buying an additional 1,783 shares in the last quarter. Park Avenue Securities LLC grew its holdings in Omega Healthcare Investors by 5.7% during the 1st quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after buying an additional 544 shares in the last quarter. Finally, HighPoint Advisor Group LLC purchased a new stake in Omega Healthcare Investors during the 4th quarter valued at approximately $758,000. 65.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Omega Healthcare Investors Trading Down 1.6 %

OHI stock opened at $39.35 on Friday. The firm has a market cap of $9.72 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00. The firm has a fifty day moving average price of $39.10 and a 200 day moving average price of $34.63. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $41.53. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The firm had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the prior year, the company posted $0.74 EPS. The company’s revenue was up 17.5% compared to the same quarter last year. Sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.81%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio is currently 241.44%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Scotiabank increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Finally, Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $36.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.